Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies

Patients with dementia with Lewy bodies (DLB) may have overlapping Alzheimer's disease pathology. We investigated the longitudinal rate of tau accumulation and its association with neurodegeneration and clinical disease progression in DLB.

[1]  W. M. van der Flier,et al.  Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study , 2020, NeuroImage: Clinical.

[2]  J. Trojanowski,et al.  Tau pathology associates with in vivo cortical thinning in Lewy body disorders , 2020, Annals of clinical and translational neurology.

[3]  C. Jack,et al.  β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies , 2020, Neurology.

[4]  Val J Lowe,et al.  Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. , 2020, JAMA neurology.

[5]  David T. Jones,et al.  Tau-positron emission tomography correlates with neuropathology findings , 2019, Alzheimer's & Dementia.

[6]  David T. Jones,et al.  The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes , 2019, Brain : a journal of neurology.

[7]  E. Kapaki,et al.  In vivo Prevalence of Alzheimer Biomarkers in Dementia with Lewy Bodies , 2019, Dementia and Geriatric Cognitive Disorders.

[8]  Stephen Salloway,et al.  A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia , 2019, Brain : a journal of neurology.

[9]  Theresa M. Harrison,et al.  Longitudinal tau accumulation and atrophy in aging and alzheimer disease , 2019, Annals of neurology.

[10]  Elisabet Englund,et al.  Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology , 2019, JAMA neurology.

[11]  David T. Jones,et al.  Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET , 2018, NeuroImage: Clinical.

[12]  E. Londos,et al.  18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies , 2018, Scientific Reports.

[13]  Christopher G Schwarz,et al.  Longitudinal tau PET in ageing and Alzheimer’s disease , 2018, Brain : a journal of neurology.

[14]  J. Graff‐Radford,et al.  The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies , 2018, Alzheimer's & Dementia.

[15]  O Almkvist,et al.  Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia , 2018, Molecular Psychiatry.

[16]  Alan J. Thomas,et al.  Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.

[17]  Clifford R. Jack,et al.  THE MAYO CLINIC ADULT LIFESPAN TEMPLATE: BETTER QUANTIFICATION ACROSS THE LIFESPAN , 2017, Alzheimer's & Dementia.

[18]  T. Montine,et al.  Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis , 2017, The Lancet Neurology.

[19]  David T. Jones,et al.  AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies , 2016, Annals of neurology.

[20]  Keith A. Johnson,et al.  Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases. , 2016, JAMA neurology.

[21]  W. M. van der Flier,et al.  Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  D. Galasko,et al.  Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies. , 2016, Parkinsonism & related disorders.

[23]  Matthew L Senjem,et al.  Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies. , 2016, Brain : a journal of neurology.

[24]  I. McKeith,et al.  Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease , 2016, Alzheimer's Research & Therapy.

[25]  David T. Jones,et al.  Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry , 2016, Movement disorders : official journal of the Movement Disorder Society.

[26]  C. Jack,et al.  A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity , 2016, NeuroImage: Clinical.

[27]  W. M. van der Flier,et al.  Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort. , 2016, Journal of Alzheimer's disease : JAD.

[28]  Jean-Paul Armspach,et al.  Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages , 2015, PloS one.

[29]  Clifford R. Jack,et al.  Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease , 2015, NeuroImage.

[30]  Clifford R. Jack,et al.  Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies , 2015, Neurobiology of Aging.

[31]  C. Jack,et al.  MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies , 2013, Neurology.

[32]  C. Jack,et al.  Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies , 2012, Neurology.

[33]  Ronald C Petersen,et al.  Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. , 2011, Sleep medicine.

[34]  Arno Klein,et al.  A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.

[35]  John Ashburner,et al.  Computational anatomy with the SPM software. , 2009, Magnetic resonance imaging.

[36]  P. Calabresi,et al.  Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies , 2008, Biological Psychiatry.

[37]  Brian B. Avants,et al.  Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..

[38]  Clifford R Jack,et al.  Rates of cerebral atrophy differ in different degenerative pathologies. , 2006, Brain : a journal of neurology.

[39]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[40]  D W Dickson,et al.  DLB fluctuations , 2004, Neurology.

[41]  D. Jeste,et al.  Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies , 2003, Neurology.

[42]  K. Jellinger,et al.  Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease , 2002, Journal of Neural Transmission.

[43]  James T Becker,et al.  Research evaluation and prospective diagnosis of dementia with Lewy bodies. , 2002, Archives of neurology.

[44]  Diane C. Tsai.  Recent Developments in Parkinson's Disease , 1986, The Yale Journal of Biology and Medicine.

[45]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .